0361-9230 < 0362-5664 < 0364-3190

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]

Ident.	Authors (with country if any)	Title
000E29 (????)	Robert A. Hauser ; Hermann Russ ; Doris-Anita Haeger ; Michel Bruguiere-Fontenille ; Thomas Müller ; Gregor K. Wenning	Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.
000F30 (????)	Pilar Salgado-Pineda ; Pauline Delaveau ; Olivier Blin ; André Nieoullon	Dopaminergic contribution to the regulation of emotional perception.
000F54 (????)	Claire Thalamas ; Iris Rajman ; Jaime Kulisevsky ; Alberto Lled ; Alison E. Mackie ; Olivier Blin ; Todd A. Gillespie ; Mary Seger ; Olivier Rascol	Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease.
001018 (????)	V. Mesnage ; J L Houeto ; A M Bonnet ; I. Clavier ; I. Arnulf ; F. Cattelin ; G. Le Fur ; P. Damier ; M L Welter ; Y. Agid	Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
001105 (????)	Mireille Gony ; Maryse Lapeyre-Mestre ; Jean-Louis Montastruc	Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs.
001116 (????)	R. Bordet ; D. Devos ; S. Brique ; Y. Touitou ; J D Guieu ; C. Libersa ; A. Destée	Study of circadian melatonin secretion pattern at different stages of Parkinson's disease.
001178 (????)	Bernard Bruguerolle ; Nicolas Simon	Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function.
001248 (????)	J L Montastruc ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre	Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
001392 (????)	S. Bourgoin ; S. Rostaing-Rigattieri ; J P Nguyen ; E. Berberich ; P. Duvaldestin ; C M Fattaccini ; M. Hamon ; F. Cesselin	Opposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation.
001393 (????)	H. Bagheri ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc	A study of salivary secretion in Parkinson's disease.
001431 (????)	F. Tison ; J. Lecaroz ; L. Letenneur ; J F Dartigues	Parkinsonism and exposure to neuroleptic drugs in elderly people living in institutions.
001536 (1997)	E. Courty ; F. Durif ; M. Zenut ; P. Courty ; J. Lavarenne	Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease.
001562 (1996)	M E Llau ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L Montastruc	A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
001574 (1996)	O. Rascol ; A J Lees ; J M Senard ; Z. Pirtosek ; J L Montastruc ; D. Fuell	Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
001575 (1996)	R. Bordet ; F. Broly ; A. Destée ; C. Libersa ; J J Lafitte	Lack of relation between genetic polymorphism of cytochrome P-450IID6 and sporadic idiopathic Parkinson's disease.
001627 (1995)	P. Limousin ; P. Pollak ; J P Pfefen ; C L Tournier-Gervason ; R. Dubuis ; J E Perret	Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease.
001661 (1994)	R. Bordet ; F. Broly ; A. Destee ; C. Libersa	Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease.
001687 (1994)	F. Durif ; D. Deffond ; G. Dordain ; M. Tournilhac	Apomorphine and diphasic dyskinesia.
001688 (1994)	F. Tison ; N. Fouillet ; P. Henry	Apomorphine increases blood glucose concentrations in Parkinson's disease.
001689 (1994)	H. Bagheri ; M. Berlan ; J M Senard ; O. Rascol ; J L Montastruc	Lacrimation in Parkinson's disease.
001718 (1993)	F. Durif ; M. Paire ; D. Deffond ; A. Eschalier ; G. Dordain ; M. Tournilhac ; J. Lavarenne	Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/ISSN.i -k "0362-5664" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/ISSN.i  \
                -Sk "0362-5664" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0362-5664
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024